Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Post by Jabookie75on Mar 06, 2019 11:50am
126 Views
Post# 29449808

Healthy consolidation

Healthy consolidationI know some people see this as games being played but I see the last two days of trading action as a very healthy consolidation.  As people have posted, the volume is reducing yet we hang around the 0.14 - 0.16 price range.  Shows me there are strong hands and a new shareholder base is being formed.  This is very healthy and encouraging.

I suspect we will trade sideways for a while unless we get a PR or some kind of news release.  If not, then we wait for year end earnings to be released in mid April and perhaps we take the next leg up after we see what progress has been made.  

Subsequent earnings will then help us to advance to our true market value as the market sees that the tunaround is underway and that the company is delivering on their earnings projections.  

We are not going to get to dollars in share price until that is proven out.  People thinking we are going to march there in a few months are delusional.  This is a long term hold and rewards will be realized as investors remain patient and the company delivers on their promises, not before.  Good luck to all.


Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse